HCV-IN-31

CAS No. 1998705-62-6

HCV-IN-31( —— )

Catalog No. M28773 CAS No. 1998705-62-6

HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 102 Get Quote
10MG 160 Get Quote
25MG 327 Get Quote
50MG 520 Get Quote
100MG 750 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    HCV-IN-31
  • Note
    Research use only, not for human use.
  • Brief Description
    HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM.
  • Description
    HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    Phospholipase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1998705-62-6
  • Formula Weight
    312.3
  • Molecular Formula
    C12H17FN6O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 60 mg/mL (192.12 mM)
  • SMILES
    C[C@@]1([C@H](n2c3nc(N)nc(NC)c3nc2)O[C@H](CO)[C@H]1O)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Riendeau D, et al. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem. 1994;269(22):15619-15624.
molnova catalog
related products
  • Letermovir

    Letermovir (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells). It targets the pUL56 subunit of the viral terminase complex.

  • GSK-2336805

    GSK-2336805 (JNJ-56914845) is a novel potent HCV NS5A inhibitor with multigenotype activity.

  • VX-222

    A potent and selective, nonnucleoside inhibitor of HCV NS5B polymerase inhibitor with Kd of 17 nM.